Dimitra Bourboulia,

Principal Investigator

​

Dr. Bourboulia received her B.S. in Clinical Diagnostic Laboratories, Technological Educational Institute of Thessaly, Greece. She earned her M.Sc. in Applied Molecular Biology of Infectious Diseases from London School of Hygiene and Tropical Medicine, University of London, England, UK. She then received her Ph.D. in Oncology from UCL, University of London where she worked on human oncogenic and immunodeficiency viruses in Prof. Robin Weiss and Prof. Chris Boshoff laboratories.

 

In 2007, Dr. Bourboulia moved to the National Institutes of Health where she jointed the laboratory of Dr. William G. Stetler-Stevenson at the National Cancer Institute in Bethesda, Maryland. There she studied the function of TIMP-2, an endogenous angiogenesis inhibitor and one of the natural inhibitors of extracellular matrix metalloproteinases (MMPs) focusing primarily on MMP-2 independent functions in various types of cancer.

 

In 2013, Dr. Bourboulia joined the Department of Urology at State University of New York Upstate Medical University.